序号	中文	英文	操作
101	Sandra Cordo, Universidad de Buenos Aires, Argentina	Sandra Cordo, Universidad de Buenos Aires, Argentina	查看中文全文00003 查看英文全文00003
102	Wian de Jongh, on behalf of the Prevent n-CoV consortium (AdaptVac, ExpreS2ion, Copenhagen University, Leiden University Medical Centre, Wageningen University and Tubingen University)	Wian de Jongh, on behalf of the Prevent n-CoV consortium (AdaptVac, ExpreS2ion, Copenhagen University, Leiden University Medical Centre, Wageningen University and Tubingen University)	查看中文全文00003 查看英文全文00003
103	Natalie Dean, University of Florida, USA	Natalie Dean, University of Florida, USA	查看中文全文00003 查看英文全文00003
104	Rafael Delgado, Hospital Universitario 12 de Octubre, Spain	Rafael Delgado, Hospital Universitario 12 de Octubre, Spain	查看中文全文00003 查看英文全文00003
105	Dimiter Dimitrov	Dimiter Dimitrov	查看中文全文00003 查看英文全文00003
106	David A. Dodd, GeoVax, Inc., USA	David A. Dodd, GeoVax, Inc., USA	查看中文全文00003 查看英文全文00003
107	Paul Duprex, Center for Vaccine Research, University of Pittsburgh, USA	Paul Duprex, Center for Vaccine Research, University of Pittsburgh, USA	查看中文全文00003 查看英文全文00003
108	Luis Enjuanes;	Luis Enjuanes; Centro Nacional Biotecnología, Spain	查看中文全文00003 查看英文全文00003
109	Jeremy Farrar, Josie Golding, Charlie Weller, on behalf of Wellcome Trust, UK	Jeremy Farrar, Josie Golding, Charlie Weller, on behalf of Wellcome Trust, UK	查看中文全文00003 查看英文全文00003
110	Mark Feinberg, Swati Gupta and Ripley Ballou, on behalf of IAVI, USA	Mark Feinberg, Swati Gupta and Ripley Ballou, on behalf of IAVI, USA	查看中文全文00003 查看英文全文00003